These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21881301)

  • 1. [Novel approach to curatives of Mibyou (presymptomatic diseases)].
    Miyata T
    Yakugaku Zasshi; 2011; 131(9):1289-98. PubMed ID: 21881301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological basis of traditional medicines and health supplements as curatives.
    Miyata T
    J Pharmacol Sci; 2007 Feb; 103(2):127-31. PubMed ID: 17287592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Royal jelly has estrogenic effects in vitro and in vivo.
    Mishima S; Suzuki KM; Isohama Y; Kuratsu N; Araki Y; Inoue M; Miyata T
    J Ethnopharmacol; 2005 Oct; 101(1-3):215-20. PubMed ID: 15946813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
    Miyata T
    Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic activities of Fatty acids and a sterol isolated from royal jelly.
    Suzuki KM; Isohama Y; Maruyama H; Yamada Y; Narita Y; Ohta S; Araki Y; Miyata T; Mishima S
    Evid Based Complement Alternat Med; 2008 Sep; 5(3):295-302. PubMed ID: 18830443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
    Chang M; Peng KW; Kastrati I; Overk CR; Qin ZH; Yao P; Bolton JL; Thatcher GR
    Endocrinology; 2007 Oct; 148(10):4793-802. PubMed ID: 17584965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
    Zhao P; Soukup ST; Hegevoss J; Ngueu S; Kulling SE; Diel P
    Planta Med; 2015 May; 81(7):578-85. PubMed ID: 26018796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the safety profiles of estrogenic Chinese herbal medicines in breast cancer.
    Yue GG; Wong LS; Leung HW; Gao S; Tsang JY; Lin ZX; Tse GM; Lau CB
    Phytomedicine; 2019 Mar; 56():103-117. PubMed ID: 30668331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Estrogenic Action Potential of Royal Jelly by Genomic Signaling Pathway in Vitro and in Vivo.
    Ishida K; Matsumaru D; Shimizu S; Hiromori Y; Nagase H; Nakanishi T
    Biol Pharm Bull; 2022 Oct; 45(10):1510-1517. PubMed ID: 35922913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veratrum nigrum inhibits the estrogenic activity of salvia miltiorrhiza bunge in vivo and in vitro.
    Xu Y; Chen T; Li X; Ya Kun Q; An JN; Zheng HX; Zhao Y; Zhang ZJ; Lin N
    Phytomedicine; 2018 Apr; 43():68-77. PubMed ID: 29747756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
    Cvoro A; Paruthiyil S; Jones JO; Tzagarakis-Foster C; Clegg NJ; Tatomer D; Medina RT; Tagliaferri M; Schaufele F; Scanlan TS; Diamond MI; Cohen I; Leitman DC
    Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique SERM-like properties of the novel fluorescent tamoxifen derivative FLTX1.
    Marrero-Alonso J; Morales A; García Marrero B; Boto A; Marín R; Cury D; Gómez T; Fernández-Pérez L; Lahoz F; Díaz M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):898-910. PubMed ID: 23727370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of estrogenic potential of Shu-Gan-Liang-Xue Decoction by dual-luciferase reporter based bioluminescent measurements in vitro.
    Zhang Y; Li PP
    J Ethnopharmacol; 2009 Nov; 126(2):345-9. PubMed ID: 19703548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
    Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
    Ju YH; Doerge DR; Helferich WG
    Food Chem Toxicol; 2008 Jan; 46(1):310-20. PubMed ID: 17919800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.